Cellectar Biosciences Presents Poster at the 58th Annual Meeting of the American Society of Hematology
MADISON, Wis., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announced that it presented a poster at the 58th Annual Meeting of the American …